Denali Therapeutics Inc. <DNLI.O>: UBS raises target price to $34 from $25
DNLI•Related News
Celsius Holdings, Inc. <CELH.O>: UBS Cuts Target Price to $44 From $50
CELH•
Encompass Health Corp <EHC.N>: UBS Raises Target Price to $155 From $150
EHC•
Under Armour forecasts steeper annual sales decline on weak North America demand
UAA•
The RealReal, Inc. <REAL.O>: UBS Raises Target Price to $16 From $14
REAL•
ExxonMobil develops Gulf Coast CO2 “carbon superhighway” network for CCS transport and storage
XOM•